BCL2 and nasopharyngeal carcinoma: This demonstrates that miR-29a downregulation is associated with drug resistance in the NPC cell line CNE-1 and that miR-29a upregulation reduces the resistance of CNE-1 cells to Taxol by inhibiting Bcl-2 and STAT3 expression.